Delivery Order SPE2DB20D3303-SPE2DB25FZ6D4
- Not listed
- AmerisourceBergen Drug Corp was awarded a competitively procured delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $42.6K and firm fixed pricing. The order, which is expected to be completed by October 10, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at approximately $32,000 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of August 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count packages) valued at $10,662.57 under a Firm Fixed Price contract type. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026....
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Tagrisso 80 mg tablets (30-count units) with a contract ceiling value of $10,662.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 1, 2025, awarded on September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $21,325.14 on September 5, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 26, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for TAGRISSO 40 mg tablets (30-count packages). The contract, valued at $10,641.07, is scheduled for completion by August 13, 2025, and represents a non-competitive set-aside delivery order placed against the company's existing Indefinite Delivery Contract with DLA. This award falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $21,325.14 under a firm fixed-price contract. This non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Tagrisso 80 mg tablets (30-count packaging) with a ceiling value of $10,662.57 under a firm fixed-price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Tagrisso 80 mg tablets in quantities of 30, with a ceiling value of $10,662.57. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents fulfillment of pharmaceutical needs for military and federal healthcare systems. The contract carries no set-aside designation, indicating it was competitively awarded....
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FZ6D4Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, PA, was awarded a delivery order valued at $10,662.57 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by May 12, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. The award was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally. As a critical vendor in the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen has demonstrated sustained capability in fulfilling federal procurement requirements across a diverse portfolio of therapeutic domains, ranging from specialty medications and vaccines to branded and generic pharmaceuticals. This particular delivery order for Tagrisso, an oncology medication, exemplifies the company's role in ensuring pharmaceutical availability for military and veteran healthcare systems. The non-set-aside designation and historical pattern of AmerisourceBergen's competitive federal contract awards reflect the company's established standing as a qualified supplier capable of meeting rigorous federal medical procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 4/21/25 |